Aller au contenu principal
2025 article

Clinical Profile and Risk Factors of Tubulointerstitial Nephritis: A Retrospective Study

0Citations signalées — pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Résumé fourni par la source

Background: Tubulointerstitial nephritis—including chronic tubulointerstitial disease (CTID), acute interstitial nephritis (AIN), and granulomatous interstitial nephritis (GIN)—are important causes of kidney disease. We examined the clinical profile of affected patients at our center. Methods: Medical records of patients diagnosed with CTID, AIN, and GIN on kidney biopsy in the nephrology department (2013–2023) were reviewed. Approved by the institute ethics committee. Results: 121 patients were included: 85 with CTID, 21 with AIN, and 15 with GIN. Median ages (IQR) were 35 (27–49), 39 (28–47), and 50 (36–55) years, respectively. Males accounted for 67.1% (CTID), 38.1% (AIN), and 46.7% (GIN). Median eGFR (IQR) at biopsy was 29.1 (16.9–46.2), 28.0 (12.2–37.5), and 26.7 (13.6–36.3) mL/min/1.73m^2, with urine protein excretion of 1.1 (0.4–2.0), 0.8 (0.4–2.0), and 0.8 (0.4–2.4) g/day in CTID, AIN, and GIN, respectively. Hematuria (≥5 RBCs/hpf) was reported in 28.2% (CTID), 47.6% (AIN), and 13.3% (GIN); pyuria (≥5 WBCs/hpf) in 41.2%, 13.3%, and 23.8%, respectively. 47 (55.3%) CTID cases had no identifiable cause while risk factors included were NSAIDs (n=15), CAM (n=11), antibiotics (n=8), chemotherapy (n=6), supplements (n=2), Sjögren’s (n=3), and IgG4-related disease (n=2). GIN was linked to sarcoidosis (n=3), TB (n=1), UTI (n=1), NSAIDs (n=2), and CAM (n=2). NSAIDs (n=6), CAM (n=2), Sjögren’s (n=3), and chemotherapy (n=2) were noted in AIN. Some had multiple risk factors. Conclusion: Tubulointerstitial diseases often manifest with kidney impairment and sub-nephrotic proteinuria. While drug exposures—both conventional and alternative—are frequently implicated, the underlying cause remains unidentified in many cases. - Variable CTID (n=85)^1 AIN (n=21)^1 Granulomatous Nephritis (n=15)^1 Age (years) 35 (25-49) 39.0 (28.0-47) 50 (36-55) Sex (Male) 57 (67.1%) 8 (38.1%) 7 (46.7%) Diabetes 6 (7.1%) 4 (19.0%) 1 (6.7%) Hypertension 34 (40.0%) 4 (19.0%) 5 (33.3%) Serum Creatinine (mg/dl) 2.6 (1.8-3.8) 2.7 (1.8-5.0) 2.7 (1.8-4.5) eGFR (ml/min/1.73m^2) 29.1 (16.9-46.2) 28.0 (12.2-37.5) 26.7 (13.6-36.3) Serum Albumin (g/dl) 4.1 (3.6-4.6) 3.8 (3.1-4.3) 4.1 (3.5-4.4) Urine Protein (g/day) 1.1 (0.4-2) 0.8 (0.4-2.0) 0.8 (0.4-2.4) Hematuria 24 (28.2%) 10 (47.6%) 2 (13.3%) Pyuria 35 (41.2%) 2 (13.3%) 5 (23.8%) n^1 (%); Median (IQR)

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Clinical Profile and Risk Factors of Tubulointerstitial Nephritis: A Retrospective Study
Date Crossref
01/10/2025
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Nephrotoxicity and Medicinal PlantsChemotherapy-induced organ toxicity mitigationSarcoidosis and Beryllium Toxicity Research

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.